Compass Therapeutics (CMPX) Treasury Shares (2019 - 2026)

Compass Therapeutics' Treasury Shares history runs 8 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 45.43% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 45.43% YoY), while the FY2025 annual figure was $1.0 million, down 72.7% from the prior year.
• Treasury Shares came in at $1.6 million for Q1 2026 at Compass Therapeutics, up from $1.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.8 million in Q4 2024 to a low of $1200.0 in Q2 2022.
• A 5-year average of $1.9 million and a median of $1.6 million in 2026 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 149900.0% in 2023 and fell as far as 87.75% in 2023.
• Compass Therapeutics' Treasury Shares stood at $900000.0 in 2022, then surged by 66.67% to $1.5 million in 2023, then surged by 151.07% to $3.8 million in 2024, then sank by 72.7% to $1.0 million in 2025, then soared by 56.23% to $1.6 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.6 million, $1.0 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison